Sign in
Explore the registryTrack Abp 206's trials

A Study to Evaluate ABP 206 Compared With OPDIVO® (Nivolumab) in Subjects With Unresectable or Metastatic Melanoma

ABP 206OngoingActive not recruitingPhase 3Open NCT06054555 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…